These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29263220)

  • 1. Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study.
    Kemppainen N; Johansson J; Teuho J; Parkkola R; Joutsa J; Ngandu T; Solomon A; Stephen R; Liu Y; Hänninen T; Paajanen T; Laatikainen T; Soininen H; Jula A; Rokka J; Rissanen E; Vahlberg T; Peltoniemi J; Kivipelto M; Rinne JO
    Neurology; 2018 Jan; 90(3):e206-e213. PubMed ID: 29263220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.
    Stephen R; Liu Y; Ngandu T; Rinne JO; Kemppainen N; Parkkola R; Laatikainen T; Paajanen T; Hänninen T; Strandberg T; Antikainen R; Tuomilehto J; Keinänen Kiukaanniemi S; Vanninen R; Helisalmi S; Levälahti E; Kivipelto M; Soininen H; Solomon A
    J Alzheimers Dis; 2017; 59(2):695-705. PubMed ID: 28671114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
    Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
    JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
    Kim HJ; Ye BS; Yoon CW; Cho H; Noh Y; Kim GH; Choi YS; Kim JH; Jeon S; Lee JM; Kim JS; Choe YS; Lee KH; Kim ST; Kim C; Kang DR; Ki CS; Lee JH; Werring DJ; Weiner MW; Na DL; Seo SW
    Neurobiol Aging; 2013 Nov; 34(11):2482-7. PubMed ID: 23769398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood viscosity in subcortical vascular mild cognitive impairment with versus without cerebral amyloid burden.
    Noh HJ; Seo SW; Jeong Y; Park JE; Kim GH; Noh Y; Cho H; Kim HJ; Yoon CW; Ye BS; Werring DJ; Na DL
    J Stroke Cerebrovasc Dis; 2014; 23(5):958-66. PubMed ID: 24589034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.
    Head D; Bugg JM; Goate AM; Fagan AM; Mintun MA; Benzinger T; Holtzman DM; Morris JC
    Arch Neurol; 2012 May; 69(5):636-43. PubMed ID: 22232206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.
    Marchant NL; Reed BR; Sanossian N; Madison CM; Kriger S; Dhada R; Mack WJ; DeCarli C; Weiner MW; Mungas DM; Chui HC; Jagust WJ
    JAMA Neurol; 2013 Apr; 70(4):488-95. PubMed ID: 23400560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later.
    Joutsa J; Rinne JO; Hermann B; Karrasch M; Anttinen A; Shinnar S; Sillanpää M
    JAMA Neurol; 2017 May; 74(5):583-590. PubMed ID: 28346588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midlife insulin resistance,
    Ekblad LL; Johansson J; Helin S; Viitanen M; Laine H; Puukka P; Jula A; Rinne JO
    Neurology; 2018 Mar; 90(13):e1150-e1157. PubMed ID: 29476033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent amyloid deposition without significant cognitive impairment among the elderly.
    Aizenstein HJ; Nebes RD; Saxton JA; Price JC; Mathis CA; Tsopelas ND; Ziolko SK; James JA; Snitz BE; Houck PR; Bi W; Cohen AD; Lopresti BJ; DeKosky ST; Halligan EM; Klunk WE
    Arch Neurol; 2008 Nov; 65(11):1509-17. PubMed ID: 19001171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of hypometabolism and amyloid levels in aging, normal subjects.
    Lowe VJ; Weigand SD; Senjem ML; Vemuri P; Jordan L; Kantarci K; Boeve B; Jack CR; Knopman D; Petersen RC
    Neurology; 2014 Jun; 82(22):1959-67. PubMed ID: 24793183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline.
    Pekkala T; Hall A; Ngandu T; van Gils M; Helisalmi S; Hänninen T; Kemppainen N; Liu Y; Lötjönen J; Paajanen T; Rinne JO; Soininen H; Kivipelto M; Solomon A
    Front Aging Neurosci; 2020; 12():228. PubMed ID: 32848707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.
    Gomperts SN; Locascio JJ; Rentz D; Santarlasci A; Marquie M; Johnson KA; Growdon JH
    Neurology; 2013 Jan; 80(1):85-91. PubMed ID: 23243071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.
    Solomon A; Turunen H; Ngandu T; Peltonen M; Levälahti E; Helisalmi S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Pajala S; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
    JAMA Neurol; 2018 Apr; 75(4):462-470. PubMed ID: 29356827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical ¹¹C-PIB uptake is associated with age, APOE genotype, and gender in "healthy aging".
    Scheinin NM; Wikman K; Jula A; Perola M; Vahlberg T; Rokka J; Någren K; Viitanen M; Rinne JO
    J Alzheimers Dis; 2014; 41(1):193-202. PubMed ID: 24603945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis.
    Stephen R; Ngandu T; Liu Y; Peltonen M; Antikainen R; Kemppainen N; Laatikainen T; Lötjönen J; Rinne J; Strandberg T; Tuomilehto J; Vanninen R; Soininen H; Kivipelto M; Solomon A;
    J Gerontol A Biol Sci Med Sci; 2021 Jul; 76(8):1407-1414. PubMed ID: 33970268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Syndrome and Amyloid Accumulation in the Aging Brain.
    Gomez G; Beason-Held LL; Bilgel M; An Y; Wong DF; Studenski S; Ferrucci L; Resnick SM
    J Alzheimers Dis; 2018; 65(2):629-639. PubMed ID: 30103324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid deposition in early onset versus late onset Alzheimer's disease.
    Cho H; Seo SW; Kim JH; Suh MK; Lee JH; Choe YS; Lee KH; Kim JS; Kim GH; Noh Y; Ye BS; Kim HJ; Yoon CW; Chin J; Na DL
    J Alzheimers Dis; 2013; 35(4):813-21. PubMed ID: 23507771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas.
    Correa DD; Kryza-Lacombe M; Zhou X; Baser RE; Beattie BJ; Beiene Z; Humm J; DeAngelis LM; Orlow I; Weber W; Osborne J
    J Neurooncol; 2018 Feb; 136(3):613-622. PubMed ID: 29168082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.